The Philadelphia Flyers announced Friday that forward Oskar Lindblom has been diagnosed with Ewing’s sarcoma. He is expected to miss the rest of the season.
Ewing sarcoma is a rare form of cancer that develops on the bones or soft tissue around the bones. The five-year overall survival rate for Ewing’s sarcoma is 70%, according to the American Cancer Society.
MORE: Travis Konecny unlimited for the Flyers
Chief Executive Chuck Fletcher wrote in a statement released Friday that Lindblom was diagnosed by specialists at the University of Pennsylvania.
“(Lindblom) will undergo further testing and evaluation next week and begin treatment immediately and is not expected to return to play for the rest of the season,” Fletcher writes. “The Flyers will do everything possible to support Oskar and help him get the best care he can.
“Out of respect for Oskar and his family, the team will have no further comments at this time and asks Oskar to have a period of privacy to focus his efforts on healing and returning to full health”.
According to Flyers.com writer Bill Meltzer, Lindblom took a day off on Monday and was not in training before missing the game on Wednesday with what was described as an upper body injury. It is not clear whether or not this is related to his diagnosis.
In 30 games this season, the 23-year-old is committed to leading the team with Travis Konecny (11) and has also added seven assists.
Lindblom was originally taken over by the Flyers in the fifth round of the 2014 NHL Draft and played the season of the 2017-18 season. Through 134 career games, he has 30 goals and 57 points.